TSH (thyroid stimulating hormone) — what your value actually means

Quick answer

TSH is the brain's signal to the thyroid: when thyroid hormone is low, TSH rises to ask for more; when thyroid hormone is high, TSH falls to ask for less. A "normal" TSH range (commonly 0.4 – 4.5 mIU/L) tells you the system is roughly in balance — but TSH alone misses two big things: whether the autoimmune process behind most US hypothyroidism is active, and whether the active thyroid hormone (T3) is actually doing its job at the tissue level.

Reference ranges and interpretation

Value / population	Classification	What it means
< 0.1 mIU/L	Suppressed	Often overt hyperthyroidism (Graves', toxic nodule), or over-replacement on thyroid medication.
0.1 – 0.4	Low	Subclinical hyperthyroidism, or normal variation.
0.4 – 2.5	Optimal-functional	The range most longevity / functional practitioners target.
2.5 – 4.5	Within reference, but watch	Statistically "normal" but at the upper edge; antibodies and symptoms matter here.
4.5 – 10	Mild elevation	Subclinical hypothyroidism. Often a Hashimoto's marker emerging.
> 10	Overt hypothyroidism	Usually warrants treatment. Symptoms typically present.

Reference ranges vary by lab. US labs commonly use 0.4 – 4.5 mIU/L; some use 0.5 – 5.0. Pregnancy ranges are different (trimester-specific).

What different values typically indicate

Suppressed TSH (< 0.1): the most likely cause is over-replacement if you're on thyroid medication. Other causes include Graves' disease, toxic nodule, or — rarely — pituitary problems. Persistent suppression on medication raises long-term risks (atrial fibrillation, bone loss) and warrants dose adjustment.

Elevated TSH (> 4.5): the most common explanation in US adults is Hashimoto's thyroiditis. The TSH elevation reflects the thyroid struggling under autoimmune attack. TPO and TgAb antibody testing should be added to confirm. Other less common causes: iodine deficiency, prior thyroid radiation, certain medications.

"Borderline" TSH (2.5 – 4.5): statistically normal but functionally suboptimal for many people. If you're symptomatic (fatigue, weight, mood, brain fog) and TSH sits in this range, the next step is to check free T4, free T3, and TPO antibodies. The full panel often reveals the actual issue.

What to look at alongside TSH

TSH is one number in a multi-marker system. The actually-useful thyroid picture includes:

- Free T4 — the inactive thyroid hormone reaching tissues
- Free T3 — the active form (often the bottleneck)
- Reverse T3 — stress-response form competing for receptors
- TPO antibodies — the autoimmune driver (defines Hashimoto's)
- Thyroglobulin antibodies — second autoimmune marker
- Iron, ferritin, vitamin D, selenium — micronutrient inputs the thyroid needs

A "normal" TSH with elevated TPO antibodies is not a normal thyroid situation. A "normal" TSH on medication with low free T3 and high reverse T3 is not a thyroid that's actually working.

Phi Longevity reads every marker on every lab you upload — together, against your history, against optimal ranges, and across time. The integrated picture tells you what a single number can't.

Start with my labs →

Frequently asked questions

My TSH is "in range" but I feel hypothyroid. What now?

Ask for free T4, free T3, and TPO antibodies. A normal TSH does not exclude active thyroid disease or suboptimal thyroid hormone availability at the tissue level.

What time of day should I get TSH drawn?

TSH is highest overnight and lowest mid-afternoon. Morning fasting draws give the most comparable longitudinal values. Drawing TSH at consistent timing across panels matters for trend interpretation.

Should I take my thyroid medication before the blood draw?

For TSH monitoring, the standard is to take medication after the draw (or at least to be consistent — your provider can interpret either, but the timing should not vary panel to panel).

Does biotin affect TSH results?

Yes. High-dose biotin (often in hair/nail supplements, 5,000+ mcg) can interfere with TSH and free T4 immunoassays, producing falsely low or falsely high results depending on the assay. Stop biotin for at least 48–72 hours before any thyroid panel.

Is a TSH of 3.2 something to worry about?

Statistically, no — that's well within the standard reference range. Functionally, it depends on symptoms and the rest of the panel. Many practitioners target the lower half of the reference range (under 2.5) for treated patients and for symptomatic individuals.

References

All citations verified against PubMed / publisher of record 2026-05-26.

1.Jonklaas J, Bianco AC, Bauer AJ, et al. (2014). Guidelines for the Treatment of Hypothyroidism: prepared by the American Thyroid Association task force on thyroid hormone replacement. Thyroid. 24(12):1670-1751. — ATA current standard for TSH reference ranges (0.4–4.5 mIU/L), treatment thresholds, and the elderly TSH-range adjustment to 4–6 mIU/L for ages 70–80.PubMed →DOI →
2.Wiersinga WM, Duntas L, Fadeyev V, Nygaard B, Vanderpump MPJ. (2012). 2012 ETA Guidelines: The Use of L-T4 + L-T3 in the Treatment of Hypothyroidism. European Thyroid Journal. 1(2):55-71. — Basis for the "treated but still symptomatic, consider T4/T3 combination" framing.DOI →
3.Cooper DS, Biondi B. (2012). Subclinical thyroid disease. Lancet. 379(9821):1142-1154. — Standard reference on subclinical hypothyroidism management; basis for treatment-threshold discussion in the 4.5–10 TSH range.PubMed →DOI →
4.Vanderpump MP, Tunbridge WM, French JM, et al. (1995). The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clinical Endocrinology (Oxf). 43(1):55-68. — Landmark prospective study; positive antithyroid antibodies + raised TSH together produce hypothyroidism odds ratios in the 38–173 range.PubMed →DOI →
5.Caturegli P, De Remigis A, Rose NR. (2014). Hashimoto thyroiditis: clinical and diagnostic criteria. Autoimmunity Reviews. 13(4-5):391-397. — Background on Hashimoto's epidemiology and antibody panel interpretation.PubMed →DOI →
6.Barbesino G. (2016). Misdiagnosis of Graves' Disease with Apparent Severe Hyperthyroidism in a Patient Taking Biotin Megadoses. Thyroid. 26(6):860-863. — Basis for the biotin-interference FAQ caveat (stop biotin ≥ 48–72h before thyroid panel).PubMed →DOI →

Functional / longevity-medicine TSH targets (under 2.5 for symptomatic patients) reflect practice positions rather than ATA guideline cutoffs. Every link above opens the PubMed abstract or publisher's DOI landing page in a new tab. All citations verified vs PubMed / publisher of record 2026-05-26.

By Steve Pinedo

Co-founder, Phi Longevity

Last updated: 2026-05-26

Steve Pinedo is the Co-founder of Phi Longevity, the AI application that turns a confusing stack of lab reports, wearable data, and clinical notes into a single, integrated picture of your health. He started Phi Longevity to make proactive health and wellness far easier to achieve. He realized how difficult it was for clients to manage their own care, records and coordination so he assembled a comprehensive M.D. led clinical team behind the platform, packaging the proactive-care experience that delivered measurable outcomes (lower triglycerides, reduced body fat, improved LDL, balanced hormones, relief from long-running autoimmune conditions) for any patient with a complicated lab to use now with an application. More about Phi Longevity →

Hashimoto's lab panel

The full thyroid + antibody pattern this marker lives in.

FSH biomarker

Companion endocrine signal.

All lab insights

Browse the full library.